Isracann Biosciences Announces OTC Trading Symbol Change to “ISCNF”, Effective November 15, 2019
November 15, 2019 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Nov. 15, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (FRA: A2PT0E) (formerly OTC: ATLED) (OTC: ISCNF) (the “Company”) an Israel-based company focused...
Annual General Meeting of Biofrontera AG: Biofrontera Management Board approved by large majority
July 11, 2019 05:23 ET
|
Biofrontera AG
Leverkusen, Germany, July 11, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced the...
Biofrontera reports preliminary unaudited sales revenue for the first six months of 2019
July 09, 2019 12:05 ET
|
Biofrontera AG
Leverkusen, Germany, July 09, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or the “Biofrontera-group”), an international biopharmaceutical...
Signature Resources Announces Listing on Frankfurt Stock Exchange
June 26, 2019 08:30 ET
|
Signature Resources Ltd.
TORONTO, June 26, 2019 (GLOBE NEWSWIRE) -- Signature Resources Ltd. (TSXV: SGU, OTCQB: SGGTF, FSE: 3S3) ("Signature" or the "Company") is pleased to announce that its common shares are now listed on...
All Biofrontera Management Board members intend to fully accept the partial tender offer by Maruho Deutschland GmbH for their shares
June 21, 2019 03:30 ET
|
Biofrontera AG
The Management Board intends to tender all personally held Biofrontera AG shares to Maruho Deutschland GmbHThe Management Board intends to help Maruho Deutschland GmbH to successfully complete its...
Blueberries Medical Lists on Frankfurt Stock Exchange Under Symbol 1OA
March 04, 2019 07:30 ET
|
Blueberries Medical Corp.
TORONTO, March 04, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Colombia-based licensed producer of medicinal...
Biofrontera receives FDA approval for upscaling of batch size for Ameluz® production
January 08, 2019 02:02 ET
|
Biofrontera AG
Leverkusen, Germany, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that...
Biome Receives DTC Eligibility
December 13, 2018 16:34 ET
|
Biome Grow
TORONTO, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Biome Grow Inc. (“Biome”or the “Company”) (CSE: BIO) (OTC: ORTFF) (FSE: 60TA) announces that it has secured The Depository Trust Company (“DTC”)...
Biofrontera to Participate in Two Upcoming Investor Conferences
November 26, 2018 13:08 ET
|
Biofrontera AG
Leverkusen, Germany, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced its...
Biome Grow Announces Listing on the Frankfurt Stock Exchange under symbol 60TA
October 18, 2018 07:30 ET
|
Biome Grow
TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- (CSE: BIO) – Biome Grow (“Biome” or the “Company”) (CSE:BIO) is pleased to announce that the Company’s common shares have been listed on the Frankfurt...